November 14, 2012
A recent study published in the open-access journal Pharmaceutical Regulatory Affairs provides shocking new evidence that viral components contained in the human papillomavirus (HPV) vaccine Gardasil are capable of crossing the blood-brain barrier and triggering cerebral vasculitis, a severe form of blood vessel inflammation in the brain that can lead to severe autoimmune disorders and even death.
A postmortem assessment of two young girls from opposite ends of the world who died recently after being given the Gardasil vaccine revealed fragments of the HPV-16L1 antigen, which is added to both Gardasil (Merck & Co.) and Cervarix (GlaxoSmithKline), inside the girls’ brain tissue. According to the study’s authors, these particles represent a genetic fingerprint of the Gardasil vaccine, which is now clearly exposed as causing serious, adverse events in at least some of the girls that receive it.
For their research, Dr. Chris Shaw from the University of British Columbia (UBC) in Canada and Dr. Lucija Tomljenovic from the Neural Dynamics Research Group in Vancouver examined samples of brain tissue taken from both girls, one 19 years old and the other 14 years old. Their analysis focused specifically on the potential presence of both HPV-16L1 and HPV-18L1, two specific antigens used in HPV vaccines.
Much to their surprise, the researchers observed that HPV-16L1 had bound itself to the walls of cerebral blood vessels in both of the girls’ brains. They also noticed increased T-cell signaling in both brain tissue samples, as well as the marked activation of the classical antibody-dependent complement pathway in the cerebral vascular tissues. Put more simply, viral components of Gardasil that never should have crossed over into the brain, were found to be fully capable of doing precisely this.
“[O]ur IHC (immunohistochemistry) analysis showed evidence of an autoimmune vasculitis potentially triggered by the cross-reactive HPV-16L1 antibodies binding to the wall of cerebral blood vessels in all examined brain samples,” says the study. “Our study suggests that HPV vaccines containing HPV-16L1 antigens pose an inherent risk for triggering potentially fatal autoimmune vasculopathies.”
Study offers definitive proof that Gardasil causes blood vessel inflammation in brain, which can lead to sudden death
Such findings are groundbreaking, as they illustrate for the first time in known history, according to the vaccine awareness group SaneVax, that a vaccine is directly linked to causing a serious, adverse event. And what better vaccine is there with which to make this discovery than Gardasil, which as of this writing has been linked to at least 27,485 adverse events, and at least 121 deaths.
Even though the sample size used in the study was small, and no control subjects used, the presence of Gardasil-specific components in the brain tissue of two different girls from opposite ends of the globe suggests the vaccine contains some type of driving mechanism by which these toxic components are able to be delivered directly into the brain. One major suspect is the aluminum adjuvant used in the vaccine, upon which HPV-16L1 and HPV-18L1 are adsorbed.
“For the average medical consumer, this evidence suggests that the antibodies produced in response to vaccination with the HPV-16L1 may cause one’s immune system to attack its own blood vessels,” wrote Norma Erickson, President of SaneVax, in a recent announcement about the study. “Given that the autopsy in both cases revealed no major abnormality (anatomically, microbiologically or toxicologically) that might have been regarded as a potential cause of death, it appears plausible that the antigenic component of the HPV vaccine (HPV-16L1) was indeed responsible for the fatal inflammation of the blood vessels.”
Sources for this article include: